Universities secure £900,000 Pfizer grant
The Universities of Leicester and Nottingham have attracted investment worth more than £900,000 from pharmaceutical giant Pfizer. The funding was secured after the two universities teamed up with Nottingham-based Source BioScience to conduct a research and development project.
The universities also secured a collaborative research and development grant of £50,000 from the healthcare and biosciences iNet.
The funding will go towards continued research on the molecular basis of lung diseases.
Dr Nick Ash, chief executive of Source BioScience, said: “We believe our UK-leading expertise and capacity in ultra-fast DNA sequencing can help the teams at Nottingham and Leicester make significant inroads into the understanding of lung disease and, in the long term, lead to the development of targeted and personalised drugs to treat patients.
"We look forward to working with the teams from Leicester and Nottingham universities on this lung disease study.”
The Healthcare and Bioscience iNet is funded by the East Midlands Development Agency (emda) and the European Regional Development Fund (ERDF).
